The Serpin-like Loop Insertion of Ovalbumin Increases the Stability and Decreases the OVA 323–339 Epitope Processing Efficiency

Daniel L. Moss, Ramgopal R. Mettu, Samuel J. LandryBiochemistry 2021 · DOI

TL;DR

This study investigates how structural changes in ovalbumin (OVA), specifically the insertion of its reactive center loop (RCL), affect the processing and presentation of a key T-cell epitope (OVA 323-339). They found that this loop insertion significantly increases protein stability and protease resistance, leading to reduced epitope presentation. This has implications for designing better vaccines and improving T-cell epitope prediction tools.

What Problem Does This Paper Address?

Understanding how proteins are broken down (processed) into smaller fragments, particularly those that can be recognized by the immune system (T-cell epitopes), is crucial for developing effective vaccines and immunotherapies. The paper focuses on ovalbumin (OVA), a well-studied protein, and its CD4+ T-cell epitope, OVA 323-339. This epitope is located near the reactive center loop (RCL) of OVA, which is part of the serpin superfamily. Serpins are known for a unique structural transition where their RCL is cleaved, and the loop inserts into a stable beta-sheet, leading to protease inactivation. While OVA itself isn't a protease inhibitor, a specific variant (OVA R339T) can undergo this loop insertion. The problem addressed is how this induced structural change, specifically the loop insertion and subsequent stabilization, impacts the accessibility and processing of the adjacent OVA 323-339 epitope, and consequently, its presentation to T-cells. This is important because the efficiency of epitope processing directly influences the immune response.

Methods

The researchers utilized several key techniques:

  • Protein Engineering and Purification: They worked with recombinant wild-type (WT) OVA and a variant, OVA R339T, which was further processed to create a loop-inserted form (OVA R339T LI) by specific elastase cleavage. Proteins were purified from E. coli.
  • Conformational Stability Assays:
    • Thermal Denaturation: Differential Scanning Calorimetry (DSC) and a bis-ANS fluorescence assay were used to measure the temperature at which proteins unfold, indicating their stability.
  • Acid and Chemical Denaturation: The bis-ANS fluorescence assay was also employed to assess protein unfolding under varying pH conditions and increasing concentrations of guanidine hydrochloride.
  • Limited Proteolysis: Proteins were incubated with lysosomal extracts from a mouse macrophage cell line (RAW264.7) and with the lysosomal protease cathepsin S. The resulting fragments were analyzed by SDS-PAGE to assess proteolytic resistance.
  • Mass Spectrometry: Fragments identified from proteolysis experiments were subjected to trypsin digestion and mass spectrometry to determine their precise sequences and identify cleavage sites.
  • Antigen Processing Likelihood (APL) Score: While not a new method in this paper, they referenced their previously developed APL score, which uses protein stability data to predict T-cell epitopes.
  • IL-2 ELISpot Assay: This immunological assay was used to measure CD4+ T-cell responses. Splenocytes from mice immunized with the OVA 323-339 peptide were restimulated in vitro with different OVA variants, and the production of IL-2 (a cytokine indicating T-cell activation) was quantified.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Loop Insertion as a Stability Switch: The induced loop insertion in OVA R339T dramatically increases its thermal stability, making it significantly more resistant to unfolding at higher temperatures compared to WT OVA.
  • Molten Globule-like State: The loop-inserted OVA R339T LI appears to exist in a molten globule-like state, characterized by increased disorder but paradoxically higher overall stability and protease resistance.
  • Epitope Shielding: The insertion of the RCL into the beta-sheet effectively "shields" the adjacent OVA 323-339 epitope, making it less accessible to proteases. This is a key mechanism for reducing epitope processing.
  • pH-Dependent Proteolysis: While loop insertion generally increases protease resistance, the differential effects of lysosomal extracts at various pH levels highlight the importance of endosomal compartment pH in antigen processing. The OVA R339T LI showed more pronounced resistance at pH 5.2, a critical stage for MHCII loading.
  • Implications for Vaccine Design: The findings suggest that engineering protein stability and altering the structural context of epitopes can be a strategy to modulate immune responses, potentially leading to more effective vaccines by controlling epitope presentation.

Key Results

  • Increased Thermal Stability: OVA R339T LI showed a significantly higher midpoint denaturation temperature (Tm) compared to WT OVA and OVA R339T, with Tm values around 85-90 °C versus ~70-75 °C.
  • Protease Resistance: Limited proteolysis experiments demonstrated that OVA R339T LI was more resistant to degradation by lysosomal extracts and cathepsin S, accumulating a stable ~28 kDa fragment containing the OVA 323-339 epitope.
  • Reduced Epitope Presentation: In IL-2 ELISpot assays, splenocytes from mice immunized with the OVA 323-339 peptide showed a significantly reduced T-cell response when restimulated with OVA R339T LI compared to WT OVA or OVA R339T. This indicates less efficient processing and presentation of the epitope from the stabilized variant.
  • Log EC50 Shift: The mean log EC50 values for T-cell stimulation were lower for OVA R339T LI (5.0) compared to WT OVA and OVA R339T (5.9), further supporting reduced epitope presentation efficiency.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study demonstrated reduced epitope presentation in vitro, further in vivo studies are needed to confirm the impact on CD4+ T-cell priming efficiency.
  • Molten Globule State: The authors note that while the molten globule state is often associated with disorder, it can also confer stability and protease resistance, which warrants further investigation.
  • Epitope Prediction Tools: The findings have direct implications for improving CD4+ T-cell epitope prediction tools by incorporating more nuanced structural and stability data. Future work will likely focus on refining these prediction algorithms.
  • Vaccine Design: The study opens avenues for designing more effective vaccines by strategically manipulating protein structure to control epitope presentation and immune responses.

Summary updated

Abstract

Chicken ovalbumin (cOVA) has been studied for decades primarily due to the robust genetic and molecular resources that are available for experimental investigations. cOVA is a member of the serpin superfamily of proteins that function as protease inhibitors, although cOVA does not exhibit this activity. As a serpin, cOVA possesses a protease-sensitive reactive center loop that lies adjacent to the OVA 323-339 CD4+ T-cell epitope. We took advantage of the previously described single-substitution variant, OVA R339T, which can undergo the dramatic structural transition observed in serpins, to study how changes in loop size and protein stability influence the processing and presentation of the OVA 323-339 epitope. We observed that the OVA R339T loop insertion increases the stability and protease resistance, resulting in the reduced presentation of the OVA 323-339 epitope <i>in vitro</i>. These findings have implications for the design of more effective vaccines for the treatment of infectious diseases and cancer as well as the development of more robust CD4+ T-cell epitope prediction tools.
BibTeX
@inproceedings{moss2021serpin,
  author = {Daniel L. Moss and Ramgopal R. Mettu and Samuel J. Landry},
  title = {{The Serpin-like Loop Insertion of Ovalbumin Increases the Stability and Decreases the OVA 323–339 Epitope Processing Efficiency}},
  booktitle = {Biochemistry},
  year = {2021},
  doi = {10.1021/acs.biochem.1c00095},
}
Figure